Team

Sophie Plante, Msc BBA

Research assistant – Coordinator Triton platform 

Michèle Orain, Bsc

Research assistant

Sylvie Châteauvert, MD

Research assistant

Clémence Boullier, Msc

PhD Student 

My PhD project aims to characterize pulmonary neuroendocrine neoplasms (NENs) both immunologically and metabolically, by identifying the cellular profiles of the tumor microenvironment and plasma signatures specific to each subtype. The goal is to better understand tumor complexity and to identify biomarkers for early diagnosis and tailored management of pulmonary NENs.

Arnaud Driussi, Ing Msc

PhD Student

My PhD project aims to identify the biological mechanisms driving lung cancer agressiveness by integrating multiple omics and tumor microenvironment approaches applied to a large cohort of tumor samples. 

Hanie Abolfathi, Msc

PhD Student

My PhD research focuses on improving prognostic stratification in lung adenocarcinoma by integrating histologic descriptors and molecular classifiers into the TNM staging system, using large clinical cohorts from Quebec and international collaborators. 

Anne-Sophie Desgagnés, Bsc

Msc Student 

My Msc project aims to characterize the tumor microenvironment (TME), with a focus on conventional dendritic cells type 1 and 2 (cDC1 and cDC2), in a cohort of 264 NSCLC patients, specifically adenocarcinomas, using the multiplex PhenoCycler-PhenoImager Fusion technology to analyze cellular composition and interactions.

Kelly-Ann Pellerin, Bsc

Msc Student 

My Msc project aims to develop and validate a prognostic gene signature for early-stage lung adenocarcinoma (LUAD) recurrence after surgical resection, using RNAseq and clinico-pathological data from the LORD discovery cohort (IUCPQ) and validating results in the TRACERx cohort, to refine molecular staging and improve patient follow-up.

Cam Bass, Bsc

Msc Student 

My Msc project aims to use transcriptomic and immunological data to find a novel clinically applicable classification structure for subgroups of patients with small-cell lung carcinoma (SCLC). In addition, we hope to identify potential biomarkers for the low-neuroendocrine subgroup of SCLC patients to improve diagnostic accuracy and propose new potential targeted therapeutic pathways.